Printer Friendly

JACOBS AWARDED CONTRACTS FROM THE LIPOSOME CO.

 JACOBS AWARDED CONTRACTS FROM THE LIPOSOME CO.
 PASADENA, Calif., March 11 /PRNewswire/ -- Jacobs Engineering Group


Inc. (NYSE: JEC) announced today the receipt of a contract from The Liposome Co. Inc. to provide engineering services for a multi-product facility to manufacture products intended for use in clinical trials.
 Jacobs is also providing the process engineering, including concept development and scale-up support, for Liposome's TLC G-65 drug, which is being developed to treat Mycobacterium avium-intracellulare (MAI) in patients with acquired immune deficiency syndrome (AIDS).
 The announcement was made by Jacobs' Group Vice President William R. Kerler who said the two New Jersey projects have targeted completion dates in 1993. The value of the contracts was undisclosed.
 The engineering services for the Liposome 15,000-square-foot clinical facility's master plan include full design development based on approved conceptual designs and project budgets, Kerler said. Key design elements include multiple universal suites with clean environments up to Class 100 to support the full range of Liposome products, now and in the future.
 The scale-up of the TLCG-65 process was designed around Jacobs' modular design expertise. Jacobs is able to develop the unit design independent of the units' final facility location, Kerler said. This approach also allows Jacobs to establish the process requirements early in the design.
 Jacobs Engineering Group, headquartered in Pasadena, provides single-source consulting, engineering, design, architectural, environmental and hazardous waste management, procurement, construction, construction management, contract maintenance and operations services to government and industry worldwide. Jacobs has 22 offices located throughout the United States and Ireland, with a major office in Somerset, N.J.
 -0- 3/11/92
 /CONTACT: Stefanie Spikell of Jacobs Engineering, 818-449-2171/
 (JEC) CO: Jacobs Engineering Group Inc.; The Liposome Company Inc. ST: California IN: CST MTC SU: CON


DM-JL -- LA004 -- 7162 03/11/92 08:03 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 11, 1992
Words:298
Previous Article:WYSE REDUCES 486 PC PRICES
Next Article:KODAK CELEBRATES NATIONAL PHOTO MONTH WITH MOTHER'S DAY CAMERA GIVEAWAY
Topics:


Related Articles
JACOBS AWARDED CONTRACT TO CONTROL BENZENE EMISSIONS AT SUN REFINERIES
JACOBS AWARDED A MAJOR UNION CARBIDE ENVIRONMENTAL PROJECT
JACOBS AWARDED $100 MILLION CONTRACT AT ROCKY MOUNTAIN ARSENAL
JACOBS AWARDED CONTRACT WITH THE U.S. ARMY CORPS OF ENGINEERS
JACOBS AWARDED $7 MILLION DEBOTTLENECKING PROJECT
JACOBS AWARDED THIRD CONTRACT WITH SYNTEX IRELAND LTD.
JACOBS AWARDED MODULAR CONSTRUCTION PROJECT BY RHONE POULENC
JACOBS AWARDED CONTRACT FROM GLOBAL OCTANES TEXAS LP
JACOBS RECEIVES MULTIMILLION CONTRACT WITH MERCK, SHARP & DOHME (IRELAND) LTD.
JACOBS RECEIVES NOx EMISSION REDUCTION PROJECT FROM EXXON

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters